Table 3.

First-line treatment in patients with peripheral T-cell lymphomas without initial CNS involvement (n = 1,027).

Chemotherapy	Patients with subsequent secondary CNS relapse (n = 16 pts)	PTCL without CNS involvement (n = 1,011 pts)
CHOP	9	570
CHOEP	7	178
Hyper-CVAD/MTX+Cytarabine	0	5
Other	0	258

CHOP, cyclophosphamide, doxorubicin, vincristine, prednisone; CHOEP, cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone; Hyper-CVAD, cyclophosphamide, vincristine, doxorubicin, dexamethasone; MTX, methotrexate.